Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

SAVE-PCI is a Prospective, Multi-center, Randomized Controlled Trial Evaluating the Safety and Efficacy of NyokAssist™ , a Small-bore Percutaneous Ventricular Assist Device (pVAD), in Comparison With Intra-aortic Balloon Pump (IABP) in Patients Undergoing Elective High-risk Percutaneous Coronary Intervention (PCI)

NCT07010965 is registered in ClinicalTrials.gov with magAssist, Inc. as lead sponsor.

NCT NCT07010965
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07010965 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
SAVE-PCI is a Prospective, Multi-center, Randomized Controlled Trial Evaluating the Safety and Efficacy of NyokAssist™ , a Small-bore Percutaneous Ventricular Assist Device (pVAD), in Comparison With Intra-aortic Balloon Pump (IABP) in Patients Undergoing Elective High-risk Percutaneous Coronary Intervention (PCI)
Lead sponsor
magAssist, Inc.
Phase
Not applicable
Overall status
Active, not recruiting
Start date
July 31, 2024
Completion date
January 31, 2026
Enrollment
236 (actual)
Sites
12

Conditions

As the registry lists them; a condition with its own page is linked.

high-risk pci